This viewpoint discusses alternative oversight for generative AI in health care, suggesting improved regulation systems.
This Viewpoint discusses current regulatory frameworks governing the use of generative artificial intelligence (AI) in health care and proposes an alternative oversight system.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: